Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
The closing price of Ovid Therapeutics Inc (NASDAQ: OVID) was $0.29 for the day, down -3.75% from the previous closing price of $0.30. In other words, the price has decreased by -$3.75 from its previous closing price. On the day, 0.5 million shares were traded. OVID stock price reached its highest trading level at $0.303 during the session, while it also had its lowest trading level at $0.283.
Ratios:
Our analysis of OVID’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 4.93 and its Current Ratio is at 4.93. In the meantime, Its Debt-to-Equity ratio is 0.24 whereas as Long-Term Debt/Eq ratio is at 0.22.
On April 30, 2024, B. Riley Securities started tracking the stock assigning a Buy rating and target price of $9.
On April 29, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $9.H.C. Wainwright initiated its Buy rating on April 29, 2024, with a $9 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Feb 26 ’25 when ALEXANDER MARGARET A. sold 5,279 shares for $0.56 per share. The transaction valued at 2,956 led to the insider holds 73,406 shares of the business.
Rona Jeffrey A sold 3,902 shares of OVID for $2,185 on Feb 26 ’25. The CBFO now owns 67,973 shares after completing the transaction at $0.56 per share. On Jan 27 ’25, another insider, ALEXANDER MARGARET A., who serves as the President and COO of the company, bought 6,810 shares for $0.73 each. As a result, the insider paid 4,971 and bolstered with 34,935 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, OVID now has a Market Capitalization of 20607534 and an Enterprise Value of -7958463. For the stock, the TTM Price-to-Sale (P/S) ratio is 37.47 while its Price-to-Book (P/B) ratio in mrq is 0.35. Its current Enterprise Value per Revenue stands at -14.523 whereas that against EBITDA is 0.15.
Stock Price History:
The Beta on a monthly basis for OVID is 0.11, which has changed by -0.9102167 over the last 52 weeks, in comparison to a change of 0.11936104 over the same period for the S&P500. Over the past 52 weeks, OVID has reached a high of $3.39, while it has fallen to a 52-week low of $0.24. The 50-Day Moving Average of the stock is -14.58%, while the 200-Day Moving Average is calculated to be -64.66%.
Shares Statistics:
OVID traded an average of 385.69K shares per day over the past three months and 382980 shares per day over the past ten days. A total of 71.11M shares are outstanding, with a floating share count of 59.51M. Insiders hold about 16.32% of the company’s shares, while institutions hold 54.46% stake in the company. Shares short for OVID as of 1745971200 were 1339819 with a Short Ratio of 3.47, compared to 1743379200 on 1210381. Therefore, it implies a Short% of Shares Outstanding of 1339819 and a Short% of Float of 2.25.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
